Soo Young Hwang (@doc_sooyoung) 's Twitter Profile
Soo Young Hwang

@doc_sooyoung

PGY-2 at UMMC Midtown ๐Ÿค“ | Harvard MPH 23โ€™ | Yonsei Med 21โ€™ ๐Ÿ‡ฐ๐Ÿ‡ท

ID: 1054732521852755968

calendar_today23-10-2018 13:53:24

18 Tweet

55 Followers

101 Following

Elliot Tapper (@ebtapper) 's Twitter Profile Photo

Checkpoint inhibitors are increasingly common and often highly effective cancer therapies But they can cause hepatitis This systematic review shows: 1 in 6 are steroid refractory 1 in 5 recurs with rechallenge Wei Zhang MD PHD Hepatology Communications journals.lww.com/hepcomm/fullteโ€ฆ

Hanna Blaney, MD, MPH (@blaneymd) 's Twitter Profile Photo

Pharmacotherapy in AUD GI/liver AE in FAERS database with Soo Young Hwang, a PGY-2 IM resident! ๐Ÿ‘๐Ÿ‘๐Ÿ‘ Love the enthusiasm and work in ALD in medical trainees #TLM24

Pharmacotherapy in AUD GI/liver AE in FAERS database with <a href="/doc_sooyoung/">Soo Young Hwang</a>, a PGY-2 IM resident! ๐Ÿ‘๐Ÿ‘๐Ÿ‘ 

Love the enthusiasm and work in ALD in medical trainees

#TLM24
Thomas G. Cotter, MD MS (@tcottermd) 's Twitter Profile Photo

Great time moderating with Dr Jessica Mellinger AASLD Varenicline for metALD? Naltrexone in decomp ALD โœ… IM naltrexone lowest GI/liver side effects Caution with Bariatric surgery in metALD Fibroscan + brief intervention โฌ‡๏ธ ๐Ÿป ALD community outreach program๐Ÿ‘

Great time moderating with Dr Jessica Mellinger <a href="/AASLDtweets/">AASLD</a> 

Varenicline for metALD?
Naltrexone in decomp ALD โœ…
IM naltrexone lowest GI/liver side effects

Caution with Bariatric surgery in metALD

Fibroscan + brief intervention โฌ‡๏ธ ๐Ÿป

ALD community outreach program๐Ÿ‘
Soo Young Hwang (@doc_sooyoung) 's Twitter Profile Photo

From attending our first #TLM2023 last year to becoming #EmergingLiverScholar and #Abstractawardee this year at #TLM2024! Always great to have a great friend along your journey #growth #liver AASLD

From attending our first #TLM2023 last year to becoming #EmergingLiverScholar and #Abstractawardee this year at #TLM2024! 
Always great to have a great friend along your journey #growth #liver <a href="/AASLDtweets/">AASLD</a>
Soo Young Hwang (@doc_sooyoung) 's Twitter Profile Photo

Grateful for all the attention our project received this #TLM2024! Meeting so many inspiring people gave me more strength to work harder for #liver#research ๐Ÿ’ช Shout out to my wonderful mentor Wei Zhang MD PHD who made all of this possible. #HepatologyStrong #ALD #AUD

Grateful for all the attention our project received this #TLM2024! Meeting so many inspiring people gave me more strength to work harder for #liver#research ๐Ÿ’ช

Shout out to my wonderful mentor <a href="/Wei_Zhang_Liver/">Wei Zhang MD PHD</a> who made all of this possible. #HepatologyStrong #ALD #AUD
Elliot Tapper (@ebtapper) 's Twitter Profile Photo

Read this A review of reported adverse events for medications to treat alcohol use disorder From Soo Young Hwang we must reduce alcohol use in people with liver disease And to increase uptake of useful tools โ€ฆ we need stop repeating that naltrexone is hepatotoxic

Read this 

A review of reported adverse events for medications to treat alcohol use disorder 

From <a href="/doc_sooyoung/">Soo Young Hwang</a> 

we must reduce alcohol use in people with liver disease 

And to increase uptake of useful tools โ€ฆ

 we need stop repeating that naltrexone is hepatotoxic
Pojsakorn Dan Danpanichkul, MD (@pojsakorndan) 's Twitter Profile Photo

๐Ÿ”ฌ๐Ÿ’Š Explore the epidemiology, risk factors, and comprehensive care continuum for HCC in this review in CLINICAL AND MOLECULAR HEPATOLOGY ๐Ÿ”— Read more: shorturl.at/wnEo9 Soo Young Hwang Ju Dong Yang Amit G Singal #livertwitter #gitwitter

๐Ÿ”ฌ๐Ÿ’Š Explore the epidemiology, risk factors, and comprehensive care continuum for HCC in this review  in <a href="/CMH_journal/">CLINICAL AND MOLECULAR HEPATOLOGY</a> 
๐Ÿ”— Read more: shorturl.at/wnEo9
<a href="/doc_sooyoung/">Soo Young Hwang</a> <a href="/JuDongYang1/">Ju Dong Yang</a> <a href="/docamitgs/">Amit G Singal</a> 
#livertwitter #gitwitter
Joseph Sleiman, MD, FACP (@josephhabibi_md) 's Twitter Profile Photo

#CGH4ALL๐Ÿ“ฃ ๐Ÿ’ฅ Injectable Naltrexone has an overall better GI and liver safety profile compared to other FDA-approved drugs for Alcohol use disorder (AUD) Wei Zhang MD PHD Soo Young Hwang CGH๐Ÿ”ฅ!๐Ÿ”— doi.org/10.1016/j.cgh.โ€ฆย  Reported by Ifrah Fatima Hanna Blaney, MD, MPH Mazen Noureddin, MD, MHSc

#CGH4ALL๐Ÿ“ฃ ๐Ÿ’ฅ
Injectable Naltrexone has an overall better GI and liver safety profile compared to other FDA-approved drugs for Alcohol use disorder (AUD) 

<a href="/Wei_Zhang_Liver/">Wei Zhang MD PHD</a> <a href="/doc_sooyoung/">Soo Young Hwang</a>

<a href="/AGA_CGH/">CGH</a>๐Ÿ”ฅ!๐Ÿ”— doi.org/10.1016/j.cgh.โ€ฆย 

Reported by <a href="/ifrahfatima/">Ifrah Fatima</a>

<a href="/BlaneyMD/">Hanna Blaney, MD, MPH</a> <a href="/NoureddinMD/">Mazen Noureddin, MD, MHSc</a>